Article

Real-World Characterization of Amyloid-Related Imaging Abnormalities (ARIA) in Lecanemab Treatment at an Academic Health System

2026-01-25

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> The benefits of amyloid-β monoclonal antibodies for Alzheimer’s disease are tempered by the risk of amyloid-related imaging abnormalities (ARIA). Detailed real-world characterization of ARIA, including incidence, timing, radiologic severity and localization, natural history, and risk factors, is essential to optimize treatment safety. This study provides a comprehensive descr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 83b8a4f6-1cea-5597-9bb4-ac471579690a
DOI: 10.64898/2026.01.23.26344739

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Real-World Characterization of Amyloid-Related Imaging Abnormalities (ARIA) in Lecanemab Treatment at an Academic Health SystemDOI 10.64898/2026.01.23.26344739Read

Real-world experience with lecanemab therapy for Alzheimer’s disease in the Intermountain WestSemantic proximity Read

MCH-Guard: Multimodal Machine Learning Framework for Risk Stratification of Cerebral Microhemorrhage Risk in the Alzheimer’s Disease Neuroimaging InitiativeSemantic proximity Read

Fatal Iatrogenic Cerebral Amyloid-Related Encephalitis in a patient treated with lecanemab for Alzheimer’s disease: neuroimaging and neuropathology.Semantic proximity Read

Fatal Iatrogenic Cerebral Amyloid-Related Encephalitis in a patient treated with lecanemab for Alzheimer’s disease: neuroimaging and neuropathologySemantic proximity Read

Reducing ARIA risk in Alzheimer's disease: Real-world impact of APOE genotype-guided slow titration with aducanumab and lecanemab.Semantic proximity Read

FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer’s Disease: Where Are We Now?Semantic proximity Read

Case Report of a 47-Year-Old Long COVID Patient Diagnosed With Alzheimer's DiseaseSemantic proximity Read

Development and clinical validation of blood-based multibiomarker models for the evaluation of brain amyloid pathologySemantic proximity Read

Relationship between APOE Genotype Status and Imaging Features in Patients with Alzheimer Disease Being Considered for Antiamyloid β Therapy.Semantic proximity Read

Anti-amyloid immunotherapy drives APOE4 specific increases in glial reactivity, perivascular immune activation, and ARIA-like eventsSemantic proximity Read

New horizons in the diagnosis and management of Alzheimer's Disease in older adults.Semantic proximity Read

Distinct serum anti-Aβ antibody patterns in hemorrhagic and inflammatory cerebral amyloid angiopathy manifestationsSemantic proximity Read